ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
COVID vaccines

Japan to shorten quarantine for J&J COVID vaccine recipients

With 3-day rule, Tokyo aims for smoother business travel from U.S. and Europe

A vial of the Johnson & Johnson COVID-19 vaccine: Japan's government intends to ease rules for passengers who have received it.   © Reuters

TOKYO -- Japan intends to expand its list of international business travelers eligible for relaxed quarantine rules to those inoculated with Johnson & Johnson's COVID-19 vaccine, Nikkei has learned.

As the government looks to boost business travel from the U.S. and Europe, the quarantine requirement for J&J recipients will be cut to as little as three days, from 14 now. The change could be made as early as this month. Japan began allowing vaccinated business travelers to enter under those conditions on Nov. 8, but only people who had received the AstraZeneca, Pfizer and Moderna vaccines -- approved for use in the country.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more